Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells

被引:16
作者
Zhang, PJ [1 ]
Zheng, JL [1 ]
Vorce, RL [1 ]
Hexum, TD [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA
关键词
bovine chromaffin cells; neuropeptide Y; receptor subtypes;
D O I
10.1016/S0167-0115(99)00093-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bovine chromaffin cells have been used in a variety of studies designed to reveal different aspects of neuropeptide Y (NPY) action. Pharmacological data have defined five NPY receptor subtypes, only one of which (Y3) has not been cloned. Some studies with bovine chromaffin cells have concluded that the effects of NPY on this cell type are mediated by the Y3 subtype. Previous work from our laboratory demonstrates that a Y1 subtype mediates the effect of NPY in this tissue. In the current studies we provide further evidence for the existence of the Y1 subtype in bovine chromaffin cells. BIBP3226, the selective Y1 antagonist, potently displaces [I-125]NPY from its binding site IC50 = 1.91x10(-9) M. Moreover, [I-125]BIBP3226 binds to bovine chromaffin cell membranes with high affinity (IC50 = 5.9 x 10(-8) M). Examination of BIBP3226 antagonism of NPY inhibition of forskolin stimulated cyclic AMP accumulation reveals that it is a competitive antagonist with a K-B similar to the IC50 for [I-125]BIBP3226 binding. Northern blot analysis using a porcine cDNA clone for the Y1 subtype demonstrates a 3.5-kb mRNA species in chromaffin cells. These data identify the bovine chromaffin cell NPY receptor as a Y1 subtype. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:9 / 13
页数:5
相关论文
共 17 条
[1]   BINDING-SITES FOR I-125-NEUROPEPTIDE-Y (NPY) ON MEMBRANES FROM BOVINE ADRENAL-MEDULLA [J].
CHERDCHU, C ;
DEUPREE, JD ;
HEXUM, TD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 173 (2-3) :115-119
[2]   BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: A review of its pharmacological properties [J].
Doods, HN ;
Wieland, HA ;
Engel, W ;
Eberlein, W ;
Willim, KD ;
Entzeroth, M ;
Wienen, W ;
Rudolf, K .
REGULATORY PEPTIDES, 1996, 65 (01) :71-77
[3]  
HEXUM TD, 1987, J PHARMACOL EXP THER, V243, P927
[4]  
HIGUCHI H, 1988, J PHARMACOL EXP THER, V244, P468
[5]   RELEASE OF NPY-LIKE IMMUNOREACTIVE MATERIAL FROM PRIMARY CULTURES OF CHROMAFFIN CELLS PREPARED FROM BOVINE ADRENAL-MEDULLA [J].
KATAOKA, Y ;
MAJANE, EA ;
YANG, HYT .
NEUROPHARMACOLOGY, 1985, 24 (07) :693-695
[6]   CHARACTERIZATION OF NEUROPEPTIDE-Y (NPY) RECEPTORS IN HUMAN HIPPOCAMPUS [J].
LI, W ;
HEXUM, TD .
BRAIN RESEARCH, 1991, 553 (01) :167-170
[7]   NEUROPEPTIDE-Y IN BOVINE ADRENAL-GLANDS - DISTRIBUTION AND CHARACTERIZATION [J].
MAJANE, EA ;
ALHO, H ;
KATAOKA, Y ;
LEE, CH ;
YANG, HYT .
ENDOCRINOLOGY, 1985, 117 (03) :1162-1168
[8]  
Michel MC, 1998, PHARMACOL REV, V50, P143
[9]  
NORENBERG W, 1995, N-S ARCH PHARMACOL, V351, P337
[10]   NEUROPEPTIDE-Y INHIBITS NICOTINIC CHOLINERGIC CURRENTS BUT NOT VOLTAGE-DEPENDENT CALCIUM CURRENTS IN BOVINE CHROMAFFIN CELLS [J].
NORENBERG, W ;
ILLES, P ;
TAKEDA, K .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1991, 418 (04) :346-352